As COFEPRIS advances to Stage 2 (confirmation) and Stage 3 (mitigation) of its national nitrosamine risk management strategy, pharmaceutical companies in Mexico face increasing pressure to validate their analytical methods and implement robust mitigation plans. With these changes creating immediate regulatory urgency, Lambda Científica, a Tentamus Company, is stepping up to guide the industry with […]
Read More